Literature DB >> 2281028

Mean interconversion times and distribution rate parameters for drugs undergoing reversible metabolism.

H Y Cheng1, W J Jusko.   

Abstract

The mean interconversion time and recycling numbers are introduced as intrinsic metabolic interconversion and distribution parameters for drugs undergoing linear reversible metabolism. Equations for these parameters, the distribution clearance, and the mean transit time in the central and peripheral compartments are derived for a metabolic pair where interconversion and elimination occur in central compartments. These parameters can be calculated from plasma concentration versus time slopes and intercepts, AUC, and AUMC data of parent drug and its metabolite partner following iv administration of each compound. The mean time analysis is illustrated with disposition data obtained previously for methylprednisolone and methylprednisone in the rabbit. Examination of mean times and additional properties of the system reveals that total exposure time of methylprednisolone is weakly influenced by the metabolic interconversion process, whereas the total exposure time of methylprednisone is strongly influenced by the process. In addition, the tissue distribution process moderately influence the total exposure times of both compounds. The derived mean time parameters, along with previously evolved equations for clearances, volumes of distribution, moments, and mean residence times allow comprehensive analysis of linear, multicompartmental reversible metabolic systems.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2281028     DOI: 10.1023/a:1015930831024

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  General method for assessing bioavailability of drugs undergoing reversible metabolism in a linear system.

Authors:  S S Hwang; W F Bayne
Journal:  J Pharm Sci       Date:  1986-08       Impact factor: 3.534

2.  Use of radioactive microspheres to assess distribution of cardiac output in rabbits.

Authors:  J M Neutze; F Wyler; A M Rudolph
Journal:  Am J Physiol       Date:  1968-08

3.  Estimation of average times of residence, recycle and interconversion of blood-borne compounds using tracer methods.

Authors:  A Rescigno; E Gurpide
Journal:  J Clin Endocrinol Metab       Date:  1973-02       Impact factor: 5.958

4.  Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? I. General considerations.

Authors:  P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1988-08

5.  Mean residence time for drugs subject to reversible metabolism.

Authors:  L Aarons
Journal:  J Pharm Pharmacol       Date:  1987-07       Impact factor: 3.765

6.  LAGRAN program for area and moments in pharmacokinetic analysis.

Authors:  M L Rocci; W J Jusko
Journal:  Comput Programs Biomed       Date:  1983-06

Review 7.  The transport of steroid hormones into animal cells.

Authors:  E P Giorgi
Journal:  Int Rev Cytol       Date:  1980

8.  A liner mode of reversible metabolism and its application to bioavailability assessment.

Authors:  S Hwang; K C Kwan; K S Albert
Journal:  J Pharmacokinet Biopharm       Date:  1981-12

9.  Reversible metabolism and pharmacokinetics: application to prednisone-prednisolone.

Authors:  J G Wagner; A R DiSanto; W R Gillespie; K S Albert
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1981-06

10.  Generalized rates of transfer in open systems of pools in the steady state.

Authors:  J Mann; E Gurpide
Journal:  J Clin Endocrinol Metab       Date:  1966-12       Impact factor: 5.958

View more
  4 in total

1.  Estimation of permanence time, exit time, dilution factor, and steady-state volume of distribution.

Authors:  J Mordenti; A Rescigno
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

Review 2.  Mean residence time of oral drugs undergoing first-pass and linear reversible metabolism.

Authors:  H Cheng; W J Jusko
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

3.  The pharmacokinetics of topotecan and its carboxylate form following separate intravenous administration to the dog.

Authors:  B E Davies; E A Minthorn; M J Dennis; H Rosing; J H Beijnen
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

4.  Plasma pharmacokinetics of lactone and carboxylate forms of 20(S)-camptothecin in anesthetized rats.

Authors:  D O Scott; D S Bindra; V J Stella
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.